KLF4 and B-cell non-Hodgkin lymphoma: The epigenetic silencing of KLF4 in B‐cell lymphomas, particularly in classical Hodgkin's lymphoma (CHL), is thought to bolster lymphoma survival through the relaxation of cell‐cycle constraints and protection from apoptosis [152].